Maryland HB1440 regulates coverage and utilization review for prescription drugs reviewed by the Prescription Drug Affordability Board.
Maryland HB1440 modifies the Maryland Medical Assistance Program and health insurance coverage to restrict certain practices by insurers, nonprofit health service plans, and health maintenance organizations regarding prescription drugs reviewed by the Prescription Drug Affordability Board. The bill prohibits these entities from requiring prior authorizations or step therapy protocols for drugs reviewed by the Board unless specific conditions are met.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.